118 related articles for article (PubMed ID: 3088159)
1. Immunohistochemical demonstration of carcinoembryonic antigen (CEA) on tissue sections from squamous cell head and neck cancer and plasma CEA levels of the patients.
Yanagawa T; Hayashi Y; Nishida T; Yoshida H; Yura Y; Azuma M; Sato M
Int J Oral Maxillofac Surg; 1986 Jun; 15(3):296-306. PubMed ID: 3088159
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of plasma carcinoembryonic antigen (CEA) in patients with head and neck cancer: correlation with tissue CEA staining].
Kawasaki T; Nagamine T; Suzuki I; Shingaki S; Nakajima T; Suzuki M
Gan No Rinsho; 1986 Feb; 32(2):133-40. PubMed ID: 2421023
[TBL] [Abstract][Full Text] [Related]
3. Carcinoembryonic antigen and head and neck cancer.
Laarman DA; van Kamp GJ; Balm AJ; Braakhuis BJ; Snow GB
Clin Otolaryngol Allied Sci; 1991 Apr; 16(2):182-6. PubMed ID: 2070537
[TBL] [Abstract][Full Text] [Related]
4. Comparison of tumor markers in patients with squamous cell carcinoma of the head and neck.
Ogawa T; Tsurusako Y; Kimura N; Nishioka S; Akagi H; Nishizaki K; Nishioka K; Rutka J
Acta Otolaryngol Suppl; 1999; 540():72-6. PubMed ID: 10445084
[TBL] [Abstract][Full Text] [Related]
5. [CEA studies in squamous cell carcinomas of the head and neck].
Schröder M; Meyer T
HNO; 1986 Aug; 34(8):334-42. PubMed ID: 3759515
[TBL] [Abstract][Full Text] [Related]
6. CYFRA 21-1 is not superior to SCC antigen and CEA in head and neck squamous cell cancer.
Wollenberg B; Jan V; Schmit UM; Hofmann K; Stieber P; Fateh-Moghadam A
Anticancer Res; 1996; 16(5B):3117-24. PubMed ID: 8920778
[TBL] [Abstract][Full Text] [Related]
7. Tissue polypeptide antigen, carcinoembryonic antigen, carbohydrate antigen, and CA125 levels as tumor markers in squamous cell carcinoma of the head and neck.
Kuo WR; Lee KW; Ho KY; Tsai SM; Chiang FY; Juan KH
Kaohsiung J Med Sci; 1999 Mar; 15(3):152-8. PubMed ID: 10224839
[TBL] [Abstract][Full Text] [Related]
8. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
[TBL] [Abstract][Full Text] [Related]
9. [The presence of CEA in spinocellular carcinoma of the oral cavity].
Airoldi M; Negri L; Pedani F; Gerbino G; Gandolfo S; Patriarca E
Boll Soc Ital Biol Sper; 1984 Apr; 60(4):871-5. PubMed ID: 6375692
[TBL] [Abstract][Full Text] [Related]
10. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
[TBL] [Abstract][Full Text] [Related]
11. The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients.
Barak V; Meirovitz A; Leibovici V; Rachmut J; Peretz T; Eliashar R; Gross M
Anticancer Res; 2015 Oct; 35(10):5519-24. PubMed ID: 26408719
[TBL] [Abstract][Full Text] [Related]
12. Detection of survivin, carcinoembryonic antigen and ErbB2 level in oral squamous cell carcinoma patients.
Li SX; Yang YQ; Jin LJ; Cai ZG; Sun Z
Cancer Biomark; 2016; 17(4):377-382. PubMed ID: 27662323
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of tumor markers in head and neck squamous cell carcinomas].
Yoneda K; Hirota J; Yamamoto T; Ueta E; Osaki T
Gan No Rinsho; 1990 Mar; 36(4):458-64. PubMed ID: 2181163
[TBL] [Abstract][Full Text] [Related]
14. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P
J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326
[TBL] [Abstract][Full Text] [Related]
15. CEA levels in head and neck cancer.
Silverman NA; Alexander JC; Chretien PB
Cancer; 1976 May; 37(5):2204-11. PubMed ID: 1260711
[TBL] [Abstract][Full Text] [Related]
16. [Significance of the CEA-Test in malignomas of the head and neck (author's transl)].
Grossenbacher R
Arch Otorhinolaryngol; 1979; 222(1):23-7. PubMed ID: 426719
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and its correlation with grading and staging on tissue sections of urinary bladder carcinomas.
Jautzke G; Altenaehr E
Cancer; 1982 Nov; 50(10):2052-6. PubMed ID: 6751517
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterisation of adenoid squamous carcinoma cells highly producing SCC antigen and CEA from carcinoma of the maxillary sinus.
Kishimoto H; Urade M; Sakurai K; Noguchi K
Oral Oncol; 2000 Jan; 36(1):70-5. PubMed ID: 10889923
[TBL] [Abstract][Full Text] [Related]
19. [Tumor markers in patients with head-neck carcinomas].
Walther EK; Dahlmann N; Gorgulla HT
Laryngorhinootologie; 1990 May; 69(5):271-4. PubMed ID: 2354022
[TBL] [Abstract][Full Text] [Related]
20. Lipid-associated sialic acid, squamous cell carcinoma antigen, carcinoembryonic antigen, and lactic dehydrogenase levels as tumor markers in squamous cell carcinoma of the head and neck.
Dreyfuss AI; Clark JR; Andersen JW
Cancer; 1992 Nov; 70(10):2499-503. PubMed ID: 1423179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
